Acucela

Current News Coverage   1/20/10 Xconomy — "Acucela Enters Fast-Growth Phase As Macular Degeneration Drug Advances to Key Trial" > View More Recent Coverage

News

 

Conferences & Events

 

Israel Society for Vision & Eye Research (ISVER),

March 11-12, 2010, Israel

Robert David, M.D., will present initial data from a Phase 1 study assessing the safety and tolerability of ACU-4429 administration in healthy volunteers aged 55-80.

Life Science Innovation Northwest, March 17, 2010, Seattle, Washington

Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, will present at Life Science Innovation Northwest, an event organized/sponsored by the group that will feature the Pacific Northwest region’s diverse life science ecosystem, and include presentations, panels and plenary sessions by leading experts from emerging and anchor device, diagnostic and biotech companies, premier research institutions and global health community. Dr. Kubota will present an overview of Acucela's novel scientific approach to treating blinding eye diseases.

University of Washington’s Global Business Forum, April 5, 2010, Seattle, Washington

Ryo Kubota, M.D., Ph.D., Acucela’s chairman, president and chief executive officer, will participate in the University of Washington’s Global Business Forum, which is an MBA class and speaker series focused on international business issues. The forum invites top Seattle region executives from private sector companies and non-profit organizations to share their perspective on working in a global business environment.

 

Current Press Releases

03/10/10 Acucela to Present at the Life Science Innovation Northwest Conference

 

03/03/10 Acucela to Participate in the 16th Nomura Bio Conference

 

03/01/10 Acucela Announces Launch of its Japanese Web Site at www.Acucela.jp

 

02/02/10 Acucela to Present at the 12th Annual BIO CEO & Investor Conference

01/20/10 Acucela to Participate in Upcoming Joint Panel of the JEF and CSIS

01/13/10 Acucela Launches ENVISION Clarity Trial; Initiates Phase 2 Clinical Trial of Oral Visual Cycle Modulator in Patients with Dry Age-Related Macular Degeneration

 

11/23/09 Acucela Data in Dry AMD to be Highlighted at ISOPT

10/23/09 Acucela CEO and Founder Selected as One of Top 25 Innovators & Entrepreneurs

10/20/09 Acucela to Present at the Second Annual Boston Biotech R&D Conference

10/01/09 Acucela to Present at the BioJapan 2009 World Business Forum

09/09/09 Acucela Appoints New Member to Board of Directors

09/02/09 Acucela to Present at Rodman & Renshaw 11th Annual Healthcare Conference

06/23/09 Acucela’s Novel Visual Cycle Modulator Demonstrates Promise as a Treatment for Dry Age-Related Macular Degeneration

05/18/09 Acucela founder to present at BIO Business Forum

05/12/09 Acucela Presents Dry AMD Therapy Data at ARVO

04/28/09 Acucela Highlights Data to be Presented at ARVO

04/07/09 Acucela Founder to Speak at C21 BioVentures Conference

03/30/09 Acucela Hires Head of Clinical Development and Regulatory Affairs

02/19/09 Acucela Founder to Speak at Ophthalmology Conference

 

> View All Press Releases